UK markets closed
  • FTSE 100

    7,494.13
    -90.88 (-1.20%)
     
  • FTSE 250

    22,263.24
    -451.74 (-1.99%)
     
  • AIM

    1,132.08
    -24.37 (-2.11%)
     
  • GBP/EUR

    1.1947
    -0.0072 (-0.59%)
     
  • GBP/USD

    1.3546
    -0.0055 (-0.40%)
     
  • BTC-GBP

    26,330.05
    -2,432.39 (-8.46%)
     
  • CMC Crypto 200

    870.86
    +628.18 (+258.85%)
     
  • S&P 500

    4,397.94
    -84.79 (-1.89%)
     
  • DOW

    34,265.37
    -450.02 (-1.30%)
     
  • CRUDE OIL

    84.83
    -0.72 (-0.84%)
     
  • GOLD FUTURES

    1,836.10
    -6.50 (-0.35%)
     
  • NIKKEI 225

    27,522.26
    -250.67 (-0.90%)
     
  • HANG SENG

    24,965.55
    +13.20 (+0.05%)
     
  • DAX

    15,603.88
    -308.45 (-1.94%)
     
  • CAC 40

    7,068.59
    -125.57 (-1.75%)
     

Changes to the 340B Program: What Covered Entitles Must Know (Webinar) - ResearchAndMarkets.com

·2-min read

DUBLIN, December 02, 2021--(BUSINESS WIRE)--The "Changes to the 340B Program: What Covered Entitles Must Know" webinar has been added to ResearchAndMarkets.com's offering.

The past few years have been an unusually tumultuous time in the 340B Program. This topic will outline the main challenges and opportunities for 340B Program stakeholders.

The presenters will underline the practical steps that 340B Program stakeholders can take to ensure compliance and optimize 340B Program participation during the current shifting state of the 340B Program.

Learning Objectives

  • You will be able to review 340B background.

  • You will be able to identify recent program changes.

  • You will be able to discuss legislative updates.

  • You will be able to recognize compliance problem areas and best practice strategies.

Key Topics Covered:

340B Background

  • General Refresher on the History of the 340B Program

  • High Level Overview of the Main Program Requirements and Regulations

  • Eligible Patient Definition Discussion and Gray Areas in Interpretation

Recent Program Changes

  • New Child Site Eligibility Rule

  • Alternative Dispute Resolution (ADR) Process

  • Medicare 340B Reimbursement Reductions

Legislative Updates

  • General Summary of Introduced Legislation That Could Impact the 340B Program and Associated Regulations in the Future

Ongoing Manufacturer Disputes

  • Background on Several Manufacturers' New Position on Offering 340B Pricing Through Contract Pharmacy Relationships

  • Introduction and Withdrawal of HHS 340B Advisory Opinion

  • Submission of HHS Enforcement Letters to Applicable Manufacturers

  • Summary of Ongoing Lawsuits Between HHS and Manufacturers Over Enforcement Letters

Compliance Problem Areas and Best Practice Strategies

  • HRSA Audit Preparations and Recent Trends in Areas of Review and Enforcement

  • 340B Billing Requirements Changes (Medicare and Medicaid) and Best Practices for Avoiding Duplicate Discounts

For more information about this webinar visit https://www.researchandmarkets.com/r/vqshlb

View source version on businesswire.com: https://www.businesswire.com/news/home/20211202005837/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting